CA
NVS icon

Commerzbank Aktiengesellschaft’s Novartis NVS Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,640
Closed -$629K – 640
2019
Q4 		$629K Sell
6,640
-4,981
-43% -$447K 0.01% 518
2019
Q3 		$1.01M Hold
11,621
– – 0.01% 533
2019
Q2 		$1.06M Buy
11,621
+3,820
+49% +$323K 0.01% 599
2019
Q1 		$672K Sell
7,801
-32,768
-81% -$2.63M 0.01% 573
2018
Q4 		$3.12M Sell
40,569
-4,761
-11% -$371K 0.03% 340
2018
Q3 		$3.5M Sell
45,330
-8,712
-16% -$644K 0.03% 339
2018
Q2 		$3.66M Buy
54,042
+6,498
+14% +$448K 0.03% 320
2018
Q1 		$3.44M Buy
47,544
+2,529
+6% +$193K 0.04% 318
2017
Q4 		$3.39M Sell
45,015
-5,832
-11% -$440K 0.04% 310
2017
Q3 		$3.91M Buy
50,847
+14,882
+41% +$1.12M 0.05% 274
2017
Q2 		$2.69M Sell
35,965
-2,847
-7% -$202K 0.05% 293
2017
Q1 		$2.58M Buy
38,812
+4,868
+14% +$324K 0.04% 325
2016
Q4 		$2.22M Buy
33,944
+724
+2% +$47K 0.03% 332
2016
Q3 		$2.35M Sell
33,220
-1,223
-4% -$89.1K 0.04% 310
2016
Q2 		$2.55K Sell
34,443
-5,531
-14% -$382K 0.02% 341
2016
Q1 		$2.6M Buy
39,974
+2,156
+6% +$147K 0.02% 331
2015
Q4 		$2.92M Buy
37,818
+287
+0.8% +$22.8K 0.02% 405
2015
Q3 		$3.09M Buy
37,531
+6,294
+20% +$560K 0.02% 368
2015
Q2 		$2.75M Hold
31,237
– – 0.01% 514
2015
Q1 		$2.76M Buy
31,237
+3,337
+12% +$296K 0.02% 522
2014
Q4 		$2.32M Hold
27,900
– – 0.01% 622
2014
Q3 		$2.35M Buy
+27,900
New +$2.26M 0.01% 698

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerzbank Aktiengesellschaft's NVS Position: Q1 2020 in Review

Commerzbank Aktiengesellschaft sold out of Novartis (NVS) in Q1 2020, closing a stake of 6,640 shares — an estimated $629K sold.

Commerzbank Aktiengesellschaft first reported a position in NVS in Q3 2014 and held it in 22 quarters. The position peaked at $3.91M in Q3 2017. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 6,640 Novartis shares in Q1 2020, an estimated $629K.
  • Commerzbank Aktiengesellschaft first reported a position in Novartis in Q3 2014 and held it in 22 quarters.
  • Commerzbank Aktiengesellschaft's Novartis position peaked at $3.91M in Q3 2017.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2020, filed 29 Apr 2020.